Hsu Jason's Form 4 filing
Immix Biopharma, Inc. (IMMX) · filed Aug 26, 2024
- Accession no.
- 0001493152-24-033900
- Filed
- Aug 26, 2024
- Trade date
- Aug 21-22, 2024
- Filing delay
- 5 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $51.7K. It was filed 5 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hsu JasonCIK 0001895035 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 21, 2024 | Common Stock | PPurchaseAcquired | +15,000 | $2.23 | +$33,450 | 837,200 | Direct | |
| Aug 22, 2024 | Common Stock | PPurchaseAcquired | +8,100 | $2.25 | +$18,225 | 845,300 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.